Skip to main content
. 2017 Nov 15;17:680–690. doi: 10.1016/j.nicl.2017.11.011

Fig. 1.

Fig. 1

Overview of experimental setup. All subjects underwent two consecutive PET-MR scan, one with placebo and one with no drug. For both scans, 11C-diprenorphine binding, brain structure, resting state fMRI and fMRI responses to pain anticipation and high or low pain stimulation and pain ratings were measured.